{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T15:53:50Z","timestamp":1722182030740},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.pnpbp.2010.09.005","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T10:38:37Z","timestamp":1284719917000},"page":"273","source":"Crossref","is-referenced-by-count":4,"title":["A case of schizophrenia with Meige syndrome induced by long-term aripiprazole successfully treated with perospirone"],"prefix":"10.1016","volume":"35","author":[{"given":"Wakako","family":"Umene-Nakano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiji","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2010.09.005_bb0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1176\/ajp.157.1.149","article-title":"Meige's syndrome associated with risperidone therapy","volume":"157","author":"Ananth","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.09.005_bb0010","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/mds.21091","article-title":"Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease","volume":"21","author":"Friedman","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2010.09.005_bb0015","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archpsyc.60.10.974","article-title":"Mechanism of new antipsychotic medications: occupancy is not just antagonism","volume":"60","author":"Grunder","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.09.005_bb0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1440-1819.1998.00408.x","article-title":"Neuroleptic induced Meige's syndrome following akathisia: pharmacologic characteristics","volume":"52","author":"Hayashi","year":"1998","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2010.09.005_bb0030","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1440-1819.2010.02092.x","article-title":"Case of tardive dystonia improved by aripiprazole","volume":"64","author":"Kato","year":"2010","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2010.09.005_bb0035","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.pnpbp.2007.10.018","article-title":"Tardive dystonic symptoms associated with aripiprazole treatment","volume":"32","author":"Lim","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.09.005_bb0040","first-page":"437","article-title":"Les convulsions de la face, une forme clinique deconvulsion faciale, bilat\u00e9rale et m\u00e9diane","volume":"20","author":"Meige","year":"1910","journal-title":"Rev Neurol"},{"key":"10.1016\/j.pnpbp.2010.09.005_bb0045","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0091-3057(98)00068-9","article-title":"Anxiolytic-like effects of perospirone, a novel serotonin-2 and dopamine-2 antagonist (SDA)-type antipsychotic agent","volume":"60","author":"Sakamoto","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2010.09.005_bb0050","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1254\/jphs.93.114","article-title":"Perospirone, a novel antipsychotic agent, hyperpolarizes rat dorsal raphe neurons via 5-HT1A receptor","volume":"93","author":"Shiwa","year":"2003","journal-title":"J Pharmacol Sci"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610003568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610003568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T01:54:29Z","timestamp":1544234069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584610003568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0278584610003568"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2010.09.005","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}